Folic acid supplementation during treatment of psoriasis with methotrexate: A randomized, double-blind, placebo-controlled trial

British Journal of Dermatology

Volumn 154, Issue 6, 2006, Pages 1169-1174

  Salim, A ^a   Tan, E ^a   Ilchyshyn, A ^a   Berth Jones, J ^a  

^a WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

Dermatology Life Quality Index; Folate; Methotrexate; Psoriasis; Psoriasis Area and Severity Index; Randomized controlled trial

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; FOLIC ACID; FOLIC ACID ANTAGONIST; FOLINIC ACID; METHOTREXATE; PLACEBO; TAR; VITAMIN D DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOLOGY LIFE QUALITY INDEX; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; FEMALE; FLATULENCE; HEADACHE; HUMAN; INDIGESTION; MALE; MOUTH ULCER; NAUSEA; PATIENT MONITORING; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PATIENT COMPLIANCE; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33646556133     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07289.x     Document Type: Article

References (13)

1. Kirby B Lyon CC Griffiths CEM Chalmers RJG Use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom Clin Exp Dermatol 2000 25 265 8
2. Boffa MJ Methotrexate for psoriasis: current European practice. A postal survey J Eur Acad Dermatol Venereol 2005 19 196 202
3. Ashcroft DM Li Wan Po A Williams HC Griffiths CEM Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality Br J Dermatol 1999 141 185 91
4. Berth-Jones J Grotzinger K Rainville C et al. A study examining inter- and intrarates reliability of three scales for measuring severity of psoriasis: psoriasis area and severity index, physician's global assessment and lattice system physician's global assessment Br J Dematol 2006 in press
5. Finlay AY Khan GK Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use Clin Exp Dermatol 1994 19 210 16
6. Shikiar R Bresnahan BW Stone SP et al. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials Health Qual Life Outcomes 2003 1 53
7. Mazzotti E Picardi A Sampogna F et al. Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis Br J Dermatol 2003 149 318 22
8. Duhra P Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis J Am Acad Dermatol 1993 28 466 9
9. Roenigk HH Fowler-Bergfeld W Curtis GH Methotrexate for psoriasis in weekly oral doses Arch Dermatol 1969 99 86 93
10. Ive FA De Saram CFW Methotrexate and the citrovorum factor in the treatment of psoriasis Trans St Johns Hosp Dermatol Soc 1970 56 45 7
11. Burkhard CG Treatment of psoriasis with methotrexate and folinic acid J Am Acad Dermatol 1980 3 207 8
12. Hills RJ Ive FA Folinic acid rescue used routinely in psoriatic patients with known methotrexate 'sensitivity' Acta Derm Venereol (Stockh) 1992 72 438 40
13. Whittle SL Hughes RA Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review Rheumatology 2004 43 267 71